A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
Active, not recruiting · NCT05297890 · Registry updated 2026-05-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer | Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer | Active, not recruiting | Phase 2 | 2026-05-19 | NCT05297890 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CStone Pharmaceuticals | 5 |
| Pfizer | 431 |
31 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.